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Epidermal growth factor (EGF) expression in the congenital polycystic
mouse kidney. The mechanisms responsible for renal cyst formation in
congenital polycystic kidney disease remain unknown, although abnor-
malities of cellular metabolism, basement membrane components, and
growth factors have been suggested. In the present study, we examined
a potential role for epidermal growth factor (EGF) in cyst formation in
a mouse model. We measured growth factor activity and concentration
in renal cyst fluid, urine, and serum obtained from mice with congenital
polycystic kidney disease (cpk). In affected mice, both growth factor
activity of urine and the urinary EGF concentration were much lower
than unaffected littermate controls even when corrected for creatinine
concentration. Although the growth factor activity was much lower in
affected mice, there were significant differences in the regional distri-
bution of EGF in animals with cysts. Both growth factor activity and
EGF concentration were greater in cyst fluid when compared to urine.
Growth factor activity in cysts was completely inhibited by anti-EGF
antibody using BALB/MK epithelial keratinocytes as targets. The
expression of EGF mRNA in kidneys from affected mice was markedly
decreased when compared to littermate controls. Theses results suggest
that decreased EGF production and local differences in EGF concen-
tration may contribute to cyst formation.
Congenital polycystic kidney disease is characterized by
epithelial cell proliferation and fluid accumulation in large cysts
[1—3]. The mechanisms responsible for this aberrant growth and
cyst formation are not known. Recent reports suggest that both
the extracellular environment and intracellular factors play
important roles. For example, alterations in basement mem-
brane protein production may result in a weakening of the
support structure for tubular cells, which could lead to cyst
formation [4—9]. Furthermore, changes in transtubular transport
manifested by increases in Na-K ATPase activity may contrib-
ute to the accumulation of fluid in cysts. Thus, both an increase
in growth as well as an increase in Na-K ATPase are associated
with cyst formation [6, 10—16].
We hypothesized that growth factors found in cysts are
important in producing the disordered epithelial cell growth
characteristic of the congenital polycystic kidney. Further-
more, we attempted to identify the specific growth factor(s)
which contributes to cyst formation. We utilized an animal
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model, the autosomal recessive congenital polycystic kidney
(cpk) mouse [17], to explore the role of growth factors in cyst
formation. In this model, affected mice progressively develop
large cysts (Fig. 1) which replace renal parenchyma leading to
renal failure and death at approximately three weeks of age. In
the present study, we measured the ability of serum, urine and
cyst fluid from affected mice and littermate controls to stimulate
parameters of growth using BALB/MK keratinocytes and tu-
bular epithelial cells from mouse kidney. To characterize the
growth factor(s) in cyst fluid we performed heparin-Sepharose
column chromatography to fractionate growth factor activity
and we inhibited growth factor activity using anti-EGF anti-
body. We also measured EGF concentrations in the same
samples by radioimmunoassay and examined EGF mRNA
expression by Northern hybridization.
Methods
Materials
Cpk mice which arose spontaneously in a branch of the
C57BL/6J inbred line (Jackson Lab.) were used in these exper-
iments. Cyst fluid, serum and bladder urine were obtained from
three-week-old affected cpk mice and their littermates. Prior to
sacrifice, animals were anesthetized with methoxyflurane (Pit-
man-Moore Inc.) and blood was collected by retro-orbital
aspiration. Animals were then sacrificed by cervical dislocation
and bladder urine and renal cyst fluid were removed. Cyst fluid
obtained from the same animal was pooled as a single sample.
All samples were stored individually at —20°C. Cyst fluid
samples from several affected animals were pooled for column
chromatography. In addition, kidneys were harvested from
two- and three-week-old mice, snap frozen in liquid nitrogen,
and stored at —70°C for future RNA extraction.
Assay of DNA synthesis in quiescent culture
BALB/MK keratinocytes, provided by Dr. Aaronson (NIH,
NCI Bethesda, Maryland, USA), were grown in minimal essen-
tial medium (MEM) with 0.05 mrvt CaC12 and 10 mg/liter Ca
pantothenate supplemented with 10% dialyzed fetal calf serum
(FCS; Gibco Laboratories, Grand Island, New York, USA) and
4 nglml of EGF (Collaborative Research) [18, 19]. Incorporation
of [3H]thymidine was utilized as an index of cell proliferation.
BALB/MK cells (2 x 104/well) were grown in 96 well plates
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Antibody blocking studies
To assess the specific role of EGF in stimulating growth, a
second set of studies was performed using a polyclonal sheep
anti-human EGF (Onco Inc.) as an antagonist. The cross
reactivity of anti-EGF antibody to mouse EGF was confirmed
by Western blot and immunostaining using normal mouse
kidney frozen sections. An identical concentration of non-
immunized sheep IgG (Cappel Inc., Cochranville, Pennsylva-
nia, USA) was used as a control.
Heparin-Sepharose column chromatography
Fig. 1. Coronal section of kidneys obtained from 3-week-old unaf-
fected (A) and affected (B) mice. (7.5 X Magnification)
Research). When cells became confluent, they were washed
twice with PBS and the medium was changed to 200 d of serum
free MEM supplemented with 5 ,ttg/ml transferrin and 1 IxM
selenium. After an additional 48 hours, the medium was
changed and serum, urine, or cyst fluid were added in a range of
concentrations. After 15 hours, 4 Ci/ml of [methyl-3H]thymi-
dine (Amersham Corp., Arlington Heights, Illinois, USA) was
added to each well and incubated for five hours at 37°C. Wells
were then washed once with ice-cold PBS and twice with
ice-cold 5% trichloroacetic acid (TCA). The TCA-insoluble
fraction was solubilized with 0.25 M NaOH, incubated for 30
minutes at 37°C, and incorporated radioactivity determined
with a liquid scintillation spectrometer (Beckman Instruments,
Fullerton, California, USA). All assays of {3H]thymidine incor-
poration were performed in duplicate and assays were repeated
at least three times. To account for differences in baseline
[3H]thymidine incorporation between assays, counts (cpm/well)
were normalized for the positive control values (cells exposed
to 10% FCS containing media). Comparisons of growth factor
activities between affected and unaffected mouse urine, and
between cyst fluid and urine from affected mice were made
using the Student's t-test.
Tubular epithelial cells were isolated from two-week-old
affected and unaffected mouse kidneys by a modification of
methods previously described [20]. The cells were grown in a
1:1 mixture of Dulbecco's Modified Eagle's Medium and Ham's
F12 Medium supplemented with 10 mM Hepes buffer, 10 nM
selenium, 5 ig/ml bovine insulin, 5 g/ml human transferrin, 5
x 10— 12 M triiodothyronine, 5 x i0 M hydrocortisone, and 25
ng/ml prostaglandin E1. Fifteen thousand renal tubule cells
were plated in each of 96 wells coated with I ig/cm2 of human
fibronectin. After the addition of cyst fluid or mouse EGF
(Collaborative Research), [3H]thymidine incorporation assays
were performed by the same methods described above for
BALB/MK keratinocytes.
To characterize the growth factor(s) in cyst fluid, heparin-
Sepharose (Pharmacia Diagnostics, Uppsala, Sweden) column
chromatography (column size 1 ml) was performed. Three
milliliters of pooled cyst fluid was applied to the column and
washed with 20 mt Tris-HC1 (pH 7.4). The column was then
eluted with a linear gradient of 0.2 to 2.0 M NaCl in Tns-HCI
(pH 7.4). Each fraction was concentrated five fold by Centrifree
MPS-l (Amicon, Lexington, Massachusetts, USA) with a mo-
lecular weight cut off of 5 kDa. Concentrate (20 d) was assayed
for biological activity by [3H]thymidine incorporation using
BALB/MK keratinocytes as described above.
EGF and creatinine concentration
The concentration of EGF in serum, urine and cyst fluid of
mice was measured using a radioimmunoassay kit (Amersham).
Briefly, antisera to EGF and [12511 EGF were added to diluted
samples and incubated for 16 hours at 4°C. A second antibody
(anti-rabbit IgG) was then added and incubated for 10 minutes
at room temperature. After centrifugation for 10 minutes at 1500
xg, supernatants were removed and the radioactivity incorpo-
rated into pellets was measured with a gamma spectrometer
(Packard Instruments, Downers Grove, Illinois, USA). Creati-
nine concentration was measured in urine and cyst fluid sam-
ples with a modified colorimetric assay using the Jaffé reaction
(Sigma Diagnostics, Sigma Chemical Co., St. Louis, Missouri,
USA). The concentration of EGF in cyst fluid was normalized
by creatinine concentration and expressed as ng/mg creatinine.
Comparisons of cyst fluid and urine from affected and unaf-
fected mice were made using the Student's t-test.
RNA extraction and Northern hybridization
Total kidney RNA was prepared from mice two and three
weeks old using guanidine-thiocyanate according to Chirgwin et
al [211. Total RNA (10 g) was electrophoresed through form-
aldehyde-agarose gels and transferred to nitrocellulose filters.
The filters were hybridized with the 754 bp SmaI/PvuII frag-
ment (bases 2886-3639) of preproEGF cDNA clone (pmegflO)
[22, 231 and /3-actin probe labeled with [32PIdCTP by the
random prime method [24]. After washing, the filter was ex-
posed to X-ray film either for three days (f3-actin probe) or two
weeks (EGF probe).
Results
Kidneys of polycystic mice were markedly enlarged by three
weeks of age (Fig. 1). Renal parenchyma was largely replaced
by expanding cysts in affected mice. In contrast, unaffected
littermates had normal kidney size and function.
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Fig. 2. Effect ofurine and cyst fluid on [3H]thymidine incorporation by
BALB/MK keratinocytes. The percent of the total volume of media
constituted by urine and cyst fluid is indicated on the abscissa and the
counts/mm of [3H] incorporated in cells (expressed as the fraction of the
counts obtained with 10% FCS) are plotted on the ordinate. The
maximum number of cpm/well for cells exposed to 10% FCS was
155,570 49,532 cpm. Bars represent the mean standard error of the
mean for urine from affected mice (; N = 7), cyst fluid (D; N = 11),
and urine from unaffected littermates (; N = 4). The asterisks indicate
the level of significance where * < 0.05, < 0.01, < 0.005.
Fig. 3. Growth factor activity of fractions eluted from a heparin-
Sepha rose column. The peak biological activity did not bind to hepann.
The gradient of elution is indicated on the right ordinate. Details of the
chromatography are described in methods.
Antibody dilution
Fig. 4. [3H]thymidine incorporation of BALB/MK cells in response to
cyst fluid in the presence of sheep anti-EGF IgG antibody (0). In each
well, media contained 2% by volume cyst fluid. Antibody dilution is
indicated on the abscissa and [3Hlthymidine incorporation is indicated
on the ordinate expressed as a % of control without antibody (100%).
The absolute value of [3H]thymidine incorporation for the cells exposed
to 2% cyst fluid without antibody was 5782 949 cpm. The mitogenic
activity of 2% cyst fluid was determined in the presence of the same
concentration and dilution of normal sheep IgG (•) and the mitogenic
activity of anti-EGF antibody was determined in the absence of cyst
fluid (A). Points represent the mean SEM of three experiments.
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The bioassay of growth factor activity in urine and cyst fluid
as measured by {3H]thymidine incorporation of BALB/MK
keratinocyte target cells is illustrated in Figure 2. Urine from
cpk mice contained significantly less (30 to 50%) growth factor
activity than that of unaffected littermates. Despite this marked
reduction in EGIF activity in the urine of animals with cysts,
significant differences in the distribution of EGF activity were
found in cyst fluid and urine of affected animals. Growth factor
activity of cyst fluid was significantly greater than that of urine
from affected animals. As shown in Figure 3, the active fraction
of the cyst fluid was contained in a single peak which did not
bind to heparin-Sepharose. This result suggested that most of
the growth factor activity in cyst fluid did not bind to heparin as
would be expected for transforming growth factor beta (TGF/3),
fibroblast growth factor (FGF), or platelet-derived growth fac-
tor (PDGF).
In order to explore the possibility that the majority of growth
factor activity in cyst fluid was due to EGF, we used anti-EGF
antibody as an inhibitor in vitro. As indicated in Figure 4,
anti-EGF antibody inhibited 98% of the growth factor activity in
cyst fluid. In contrast, anti-EGF antibody inhibited only 30% of
the growth factor activity found in normal mouse serum (data
not shown).
Renal function of cystic animals is markedly impaired by two
to three weeks. Therefore, we measured creatinine concentra-
tion in the same cyst fluid and urine samples in which the
concentration of immunoreactive EGF was determined. In
urine of affected mice, EGF/Cr was significantly less than that
0 1:25000 1:5000 1:1000 1:200
of normal littermates (Fig. 5). However, similar to the results
obtained for growth factor activity, the concentration of EGF/
creatinine in cyst fluid was significantly greater than that of
urine.
In order to determine whether the growth factor in cyst fluid
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Fig. 5. EGF concentration of urine and cyst fluid measured by radio-
immunoassay. Data were normalized by creatinine concentration of
each sample. Bars represent mean standard error of the mean.
Asterisk indicates significance where *13 < 0.001.
was biologically active for renal cells, we evaluated the effect of
cyst fluid on DNA synthesis of tubular epithelial cells (Fig. 6).
Kidney epithelial cells isolated from normal and cystic mice
were capable of responding to the growth factors in cyst fluid as
well as to authentic EGF in a manner similar to that of
BALB/MK keratinocytes. The maximal stimulation of [3H]thy-
midine incorporation occurred when 1% of the medium by
volume was composed of cyst fluid. Although there were
marked and significant differences in urinary growth factor
activity and EGF/creatinine concentration between affected
and unaffected littermates, the differences in serum growth
factor activity and serum EGF concentration were not signifi-
cant (Fig. 7).
The expression of mRNA for preproEGF in affected and
unaffected littermate mouse kidneys was analyzed by Northern
hybridization (Fig. 8). The preproEGF mRNA from affected
mouse kidneys was markedly less than that from unaffected
littermates at both two and three weeks. In contrast, beta actin
mRNA was increased in affected mice when compared to
unaffected controls at three weeks, probably reflecting the
marked proliferative state of cyst formation [9, 34].
Discussion
Both genetic and environmental factors are important for cyst
formation, particularly in the autosomal dominant forms of
polycystic kidney disease. While this may be less true in the
autosomal recessive forms of the disease, the cpk mouse
provides a good model for the evaluation of potentially impor-
tant modifying factors.
In the cpk mouse, changes in extracellular matrix compo-
nents, cell proliferation, and transepithelial transport of solute
and water likely contribute to the development of cysts. For
example, an increase in the expression of mRNA of basement
membrane components has been reported in cpk mice [9].
Various chemical agents, such as the antioxidants diphenyl-
amine (DPA) [25], nordihydroguaiaretic acid (NDGA) [1] and
2-amino-4,5-diphenylthiazole (DPT) [4, 5, 26], and hormones,
such as triiodothyronine [15] and hydrocortisone [27] have been
reported to cause tubule cell hyperplasia and cyst formation in
rats. In addition to these effects, DPT decreases tubule proteo-
glycan synthesis, one of the major basement membrane com-
ponents [6, 71. Studies using organ or cell culture systems
suggest that increased Na-K ATPase activity and increased
intracellular cyclic AMP concentration induce cyst formation
[6, 12, 15, 28, 29] and Na concentration influences kidney
epithelial cell growth in culture [11, 14]. Furthermore, EGF
activates Na transport in fibroblasts and has been implicated
in breast cyst formation as well [30—32]. Therefore, we hypoth-
esized that alterations in growth factor activity, particularly
EGF, might be important in cyst formation since EGF stimu-
lates both cell growth and Na/K transport.
In the present study, we found that urine from affected mice
had profoundly reduced growth factor activity when compared
to unaffected littermates. However, cyst fluid had much higher
growth factor activity than urine from affected mice. The
growth factor activity which we measured using BALB/MK
mouse epithelial keratinocytes as targets stimulated renal epi-
thelial cell growth as well. In order to better define this factor,
we characterized the major growth factor activity in cyst fluid
using heparin-Sepharose column chromatography. The major-
ity of growth factor activity for BALB/MK epithelial kerati-
nocytes was found in a single peak which did not bind to
heparin. Furthermore, growth factor activity of this peak was
almost completely inhibited by anti-EGF antibody, suggesting
that EGF was the predominant growth factor for epithelial cells
in cyst fluid. In order to confirm this possibility, we measured
EGF concentration in cyst fluid, urine and serum in both
affected and unaffected mice. These values were normalized for
creatinine concentration since cystic animals have markedly
impaired renal function and, as a result, likely do not concen-
trate urine normally. In affected animals, the urinary EGFI
creatinine of affected mice was much less than normal litter-
mates. The ratio of EGF/creatinine concentration in cyst fluid
was much greater than that of urine from affected animals.
These results paralleled the findings observed for growth factor
activities as measured by bioassay. The reason for the increase
in cyst fluid EGF/creatinine concentration in affected animals
when compared to urine is unclear, but probably reflects local
sites of production and accumulation.
To evaluate whether the decrease in EGF was due to a
reduction in gene expression, whole kidney RNA was probed
for the presence of EGF mRNA. Affected animals had a marked
reduction in EGF message when compared to normal litter-
mates. Normally, preproEGF mRNA expression increases in
the kidney for the two weeks following birth [23, 33]. While
there was a slight increase in preproEGF mRNA in cpk mice
between two and three weeks, the level was markedly reduced
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Fig. 7. A. [3H]thymidine incorporation assay of
affected () and unaffected (•) mouse serum
using BALB/MK keratinocyte target cells. The
volume percent of serum in media is plotted on
the abscissa and counts of incorporated [3H]
normalized for the control (relative value in cpm/
well for [3H]thymidine incorporation exposed to
10% FCS containing media) are plotted on the
Affected Unaffected ordinate. B. EGF concentration in serum of
serum serum affected and unaffected mice measured by
N = 5 N = 11 radioimmunoassay.
when compared to unaffected littermates. These results also
paralleled the findings observed for EGF concentration as
measured by radioimmunoassay. Gattone et al reported defec-
tive preproEGF expression in cpk mice by immunohistochem-
ical study and Northern hybridization [34] and our data also
strongly suggest that EGF regulation is impaired in the cpk
model. While EGF/creatinine concentration in urine is reduced
in cpk mice, EGF accumulating locally in renal cysts may act as
a mitogen for renal tubular epithelial cells and may stimulate
Na-K ATPase.
It appears likely that the presence of EGF is required for
normal renal development and that decreased EGF production
may contribute to renal cyst formation. As a result, local
differences in EGF concentration may determine the specific
location and distribution of cysts which form in the kidney.
However, it is conceivable that the response of epithelial cells
from cystic animals is impaired as well. Carone et al reported
that cyst-derived epithelial cells obtained from human autoso-
ma! dominant polycystic kidneys do not respond to EGF to the
same extent as normal cells [35]. However, in the present
study, tubule epithelial cells from affected and unaffected mice
responded to EGF and cyst fluid similarly. The differences
between these findings and those of Carone et al may be due to
species differences as well as differences in the genetics of the
disease. In addition, the cell types responsible for cyst forma-
tion are not clear. Taub et al reported that renal tubule epithelial
cells prepared from the cpk mouse model contained abundant
2Ws 2Ws
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Fig. 8. Northern hybridization of EGF and f3-actin. A. EGF mRNA
expression of 2- and 3-week-old affected mice and normal littermates.
After hybridization with a cDNA probe for EGF, washed filters were
exposed for 14 days. B. The same filter was hybridized with a p-actin
cDNA probe. C. Ethidium bromide staining of the gel.
alkaline phosphatase activity, suggesting a proximal tubule
origin [36]. However, Preminger et al [17] and Gattone et al [37]
have reported that renal cyst formation in the mouse model
occurs first in proximal tubules and then involves the collecting
7.0 B
0 2.0 4.0 6.0
Fig. 6. Mitogenic effects of EGF and cyst fluid
6.0
5.0 using tubular epithelial target cells obtained from
normal (0) and cystic (•)mouse kidneys. Various4.0 amounts of EGF and cyst fluid were added to the
media and TCA-insoluble incorporation of3.0 [3Hlthymidine was measured as described in
2.0 methods. The counts/mm of [3H]thymidineincorporated into cells are expressed as a relative
1.0 value compared to control (without mitogens). The
0.0 1.0 2.0 3.0 4.0 absolute values for {3H]thymidine incorporation for
affected and unaffected mouse cells in the absence of
Concentration of EGF, ng/mI Concentration of cyst fluid, % mitogen were 361 cpm and 1,313 cpm, respectively.
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duct secondarily. As a result, different cell types may be
involved at different stages of the disease.
In summary, cyst formation is associated with marked cellu-
lar proliferation. Although EGF is markedly reduced in affected
mice, the local accumulation of EGF in cysts may play an
important role in cyst formation. Furthermore, the marked
changes in EGF regulation may be critical for the disorganized
growth pattern typical of the cpk mouse model.
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